FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

424646001: Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3678502014 Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3678504010 Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2641705014 Efavirenz 600mg/emtricitabine 200mg/tenofovir 300mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2645812015 Efavirenz 600mg/emtricitabine 200mg/tenofovir 300mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3487312017 Product containing efavirenz 600 mg and emtricitabine 200 mg and tenofovir 300 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3495670014 Product containing efavirenz 600 mg and emtricitabine 200 mg and tenofovir 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3502131018 Efavirenz 600 mg and emtricitabine 200 mg and tenofovir 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570464011 Product containing only efavirenz 600 mg and emtricitabine 200 mg and tenofovir 300 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3570465012 Product containing only efavirenz 600 mg and emtricitabine 200 mg and tenofovir 300 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3678502014 Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3678503016 Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3678504010 Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil fumarate 300 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Is a Product containing efavirenz and emtricitabine and tenofovir (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Emtricitabine (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tenofovir disoproxil fumarate (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Efavirenz (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Is a Product containing efavirenz and emtricitabine and tenofovir in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Tenofovir disoproxil fumarate (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) Tenofovir disoproxil fumarate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator value 300 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Efavirenz (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) Efavirenz (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator value 600 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Emtricitabine (substance) false Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has basis of strength substance (attribute) Emtricitabine (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has presentation strength numerator value 200 false Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient Tenofovir disoproxil fumarate (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient Efavirenz (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Has precise active ingredient Emtricitabine (substance) true Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Count of base of active ingredient trois false Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Is a Efavirenz and emtricitabine and tenofovir only product in oral dose form true Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet Plays role Antiretroviral therapeutic role false Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start